Medochemie Hellas the fastest growing generic company in Greece
Medochemie Hellas, is one of the 23 companies that were awarded the distinction of Business Excellence «Salus Index 2014». The ceremony was held on Thursday evening at Radisson Blu Park Hotel in Athens and was organized by Active Business Publishing – Stat Bank.
In a year in which the economic crisis continues to adversely affect businesses, these 23 companies –from the health, drug and beauty sectors- not only endured but achieved remarkable growth and profitability in the Greek market. The Business Excellence «Salus Index 2014» award recognizes this achievement. Among the companies receiving the award, were the following: VIANEX, Pharmathen, Gilead Sciences Hellas, Novartis Hellas, Boehringer Ingelheim Hellas, Pfizer Hellas, Jansen Cilag, MSD, Unilever Hellas, Medochemie, Sanofi Aventis.
The companies awarded came from a broad spectrum of sectors: pharmaceutical companies, drug wholesalers, cosmetics, medical equipment, food supplements and showed achievement in the following areas: profit growth, increased recruitment, big investment, R&D and innovation.
Medochemie’s prize was received by Mr Antonis Efmorfiades, General Manager for Medochemie Hellas. Also attending the event was Mr Constantinos Pittas, member of the Board of Directors of Medochemie.
Mr. Antonis Efmorfiades noted that Medochemie Hellas’ strong performance during the 3 years was due to the efforts from all its employees, acting in accordance with the company’s values: Passion for what we do, People attracting, developing and retaining the best, Flexibility and agility without compromising quality, Dedication to patient well-being, Professionalism and integrity.
The event was attended by healthcare professionals, political and business leaders as well as members of the press.